Literature DB >> 27123993

Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014.

Stacie B Dusetzina1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27123993     DOI： 10.1001/jamaoncol.2016.0648

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  34 in total

1.  Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues.

Authors:  Patricia M Danzon
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

2.  Diffusion of Bevacizumab Across Oncology Practices: An Observational Study.

Authors:  Nancy L Keating; Haiden A Huskamp; Deborah Schrag; John M McWilliams; Barbara J McNeil; Bruce E Landon; Michael E Chernew; Sharon-Lise T Normand
Journal:  Med Care       Date:  2018-01       Impact factor: 2.983

3.  The social and economic toll of cancer survivorship: a complex web of financial sacrifice.

Authors:  Matthew P Banegas; Jennifer L Schneider; Alison J Firemark; John F Dickerson; Erin E Kent; Janet S de Moor; Katherine S Virgo; Gery P Guy; Donatus U Ekwueme; Zhiyuan Zheng; Alexandra M Varga; Lisa A Waiwaiole; Stephanie M Nutt; Aditi Narayan; K Robin Yabroff
Journal:  J Cancer Surviv       Date:  2019-05-23       Impact factor: 4.442

4.  Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.

Authors:  Stacie B Dusetzina; Haiden A Huskamp; Aaron N Winn; Ethan Basch; Nancy L Keating
Journal:  JAMA Oncol       Date:  2018-06-14       Impact factor: 31.777

5.  Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies.

Authors:  Ashley L Cole; Hanna K Sanoff; Stacie B Dusetzina
Journal:  JAMA Intern Med       Date:  2017-11-01       Impact factor: 21.873

6.  Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act.

Authors:  Ryan D Nipp; Amy M Shui; Giselle K Perez; Anne C Kirchhoff; Jeffrey M Peppercorn; Beverly Moy; Karen Kuhlthau; Elyse R Park
Journal:  JAMA Oncol       Date:  2018-06-01       Impact factor: 31.777

7.  From the Guest Editor: The Affordable Care Act and Cancer Care.

Authors:  Nancy L Keating
Journal:  Cancer J       Date:  2017 May/Jun       Impact factor: 3.360

Review 8.  Understanding Financial Hardship Among Cancer Survivors in the United States: Strategies for Prevention and Mitigation.

Authors:  K Robin Yabroff; Cathy Bradley; Ya-Chen Tina Shih
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

9.  Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.

Authors:  Ya-Chen Tina Shih; Ying Xu; Lei Liu; Fabrice Smieliauskas
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

Review 10.  The high price of anticancer drugs: origins, implications, barriers, solutions.

Authors:  Vinay Prasad; Kevin De Jesús; Sham Mailankody
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.